Skip to Main Content

For US residents only, excluding Puerto Rico

Important Safety Information
  • Medication Guide
  • Important Safety Information
  • Prescribing Information
  • For Healthcare Professionals
  • Other Indication
CAPLYTA® (lumateperone) for schizophrenia homepage
  • About Schizophrenia
  • About Caplyta
  • Side Effects
  • Taking Caplyta
  • Savings Offer & Cost
    • Talking to a healthcare provider
    • Patient & caregiver support
    • Frequently asked questions
  • Savings Card
Savings Card
  • About Schizophrenia
  • About Caplyta
  • Side Effects
  • Taking Caplyta
  • Savings Offer & Cost
    • Talking to a healthcare provider
    • Patient & caregiver support
    • Frequently asked questions
  • Savings Card
Learn about speaking with a healthcare provider

For US residents only, excluding Puerto Rico

  • For Healthcare Professionals
  • Medication Guide

CAPLYTA is an FDA-approved medicine proven to
help control the symptoms of schizophrenia in adults

Find out if real progress may be possible with CAPLYTA

About schizophrenia

Schizophrenia affects people in different ways

Learn more about schizophrenia

Side effects

Find out what to expect when taking CAPLYTA

Learn more about side effects

Savings offer & cost*

Explore ways you might save on CAPLYTA

Learn more about savings and support

Edgar's story

Get a personal perspective on CAPLYTA

Watch now

How do you see progress?

Progress is personal. How do you measure yours?

Watch the CAPLYTA TV commercial

Go to Intra-Cellular Therapies, Inc. homepage
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us
  • ITCI Corporate Site
  • Sitemap
  • Do Not Sell My Personal Information
  • AdChoices Opt-out

CAPLYTA is a registered trademark and LYTAlink is a trademark of Intra-Cellular Therapies, Inc.

All other trademarks and registered trademarks are the property of their respective owners.

© 2022 Intra-Cellular Therapies, Inc. All rights reserved. US-CAP-2100544 05/22